Market Developments: A Morning Overview

Novo Nordisk Shares Surge After FDA Approval

Shares in Novo Nordisk have surged 7.5% this morning following the U.S. FDA’s approval of the first oral weight-loss drug, Wegovy.

Yesterday marked a significant milestone as the FDA granted approval for Wegovy in pill form, making it the first daily oral medication to combat obesity. This is a noteworthy advancement in the weight-loss sector, especially as competition heats up.

• The FDA’s decision gives Novo Nordisk a competitive edge over Eli Lilly, whose oral obesity drug, orforglipron, is still pending review.
• This approval is a much-needed boost for Novo Nordisk, whose share prices have nearly halved this year due to increasing competition.

Ryanair’s Legal Challenges: An Appeal Against Competition Authority Ruling

In a bold move, Ryanair has announced its immediate intention to appeal a €256 million fine imposed by Italy’s competition authorities, labeling the ruling as “legally flawed” and “bizarre.”

The budget airline maintains that its direct sales model benefits consumers by providing lower fares, a principle upheld by a previous Milan Court ruling.

Ryanair stated, “The ruling seeks to ignore the January 2024 precedent which confirmed that our model undoubtedly benefits consumers.”

• Ryanair argues that the fine and ruling undermine its competitive practices.
• The airline claims that its approach is designed to enhance competition rather than stifle it.

Bet365’s Leadership: Profits vs. Payouts

Denise Coates, CEO of Bet365, reported a substantial £280 million in pay and dividends for 2025, despite a noticeable decline in pre-tax profits.

Bet365’s turnover rose to £4 billion, but expenses surged by £325 million as the company restructured its global operations, particularly expanding in the U.S. and South America while exiting the controversial Chinese market.

• Coates has extracted over £2.5 billion from the company she founded in a car park.
• Despite the profit slump, her earnings have increased compared to last year’s £150 million.

EU Car Market Trends

This year’s data reveals that hybrid-electric vehicles now represent 34.6% of the total EU car market.

In total, over 3.4 million hybrid-electric cars have been registered across the EU this year, with notable growth in key markets such as:

• Spain (+26%)
• France (+24.2%)
• Germany (+8.7%)
• Italy (+7.9%)

Furthermore, plug-in hybrids now account for 9.3% of sales, while battery-electric vehicles hold a 16.9% market share, suggesting a shift towards more sustainable options.

Tesla’s Sales Decline in Europe

Despite a challenging month, Tesla’s sales in Europe fell sharply, with a reported 34.2% decline in registrations year-on-year.

Factors contributing to this downturn include:

• Increased competition from Chinese manufacturers like BYD, which saw a 221% sales increase in the EU.
• A consumer backlash against CEO Elon Musk’s political involvement during his time with the Trump administration.

Interestingly, while Tesla struggled, the Norwegian market presented a silver lining with a 34.6% rise in sales, led by the Model Y crossover.

Conclusion

This morning’s updates highlight a dynamic business landscape, characterized by significant developments in pharmaceuticals, airlines, gambling, and automotive markets. As companies navigate these challenges and opportunities, their strategies in response to market pressures will be pivotal for future success.

For more detailed information, please read the original news at the source: The Guardian.